Histoplasmosis Complicating Tumor Necrosis Factor–α Blocker Therapy: A Retrospective Analysis of 98 Cases

Background. Histoplasmosis may complicate tumor necrosis factor (TNF)–α blocker therapy. Published case series provide limited guidance on disease management. We sought to determine the need for long-term antifungal therapy and the safety of resuming TNF-α blocker therapy after successful treatment...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Vergidis, Paschalis, Avery, Robin K., Wheat, L. Joseph, Dotson, Jennifer L., Assi, Maha A., Antoun, Smyrna A., Hamoud, Kassem A., Burdette, Steven D., Freifeld, Alison G., McKinsey, David S., Money, Mary E., Myint, Thein, Andes, David R., Hoey, Cynthia A., Kaul, Daniel A., Dickter, Jana K., Liebers, David E., Miller, Rachel A., Muth, William E., Prakash, Vidhya, Steiner, Frederick T., Walker, Randall C., Hage, Chadi A.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4796723/
https://ncbi.nlm.nih.gov/pubmed/25870331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ299
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados